| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-13 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-12 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-12 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-11 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-10 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-10 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-10 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-10 |